ING Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,815	Closed	-$343K	–	633
2019 Q2	$343K	Sell	4,815 -207	-4%	-$14.7K	0.01%	624
2019 Q1	$394K	Sell	5,022 -201	-4%	-$15.8K	0.01%	527
2018 Q4	$442K	Buy	+5,223	New	+$442K	0.01%	489